AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 07/15/21

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:00 a.m. Eastern ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors like cheap shares, particularly those under $10, and frequently put them on their lists of “stocks to watch.” After all, many of today’s market darlings were trading at much lower values ...

The global economic recovery can be attributed in large measure to the efforts of several healthcare companies in their race to develop a COVID-19 vaccine. With governments now pouring billions of dollars to further improve the healthcare industry, and companies in the sector focusing on meet...

Amneal Pharmaceuticals (AMRX) announces that the U.S. FDA has accepted for review the Biologics License Application ((BLA)) for Bevacizumab for the treatment of metastatic colorectal cancer.Shares up more than 8% premarket.The health regulator has also set a standard review goal dat...

- Bevacizumab represents the third biosimilar BLA currently filed by Amneal with the FDA Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the Food and Drug Administration recently accepted Amneal’s 505(b)(2) New Drug Application for a newly licensed dihydroergotamine (DHE) prefilled syringe autoinj...

Image source: The Motley Fool. Amneal Pharmaceuticals, Inc. (NYSE: AMRX) Q1 2021 Earnings Call May 7, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcr...

Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Conference Call May 07, 2021, 08:30 ET Company Participants Anthony DiMeo - IR Chintu Patel - Co-Founder, Co-CEO & Director Chirag Patel - Co-Founder, Co-CEO, President & Director Anastasios Konidaris - EVP & CFO Joseph Todisco ...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Amneal Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation

Amneal Pharmaceuticals (AMRX) posted first-quarter revenue that fell short of Wall Street estimates, partly hurt by decreased influenza activity during the period, and maintained its full-year forecast.Revenue during the quarter fell 1% to $493.1M, due to the higher customer pu...